ClinicalTrials.gov
public full text
Public Domain
Effect of Xolair on Airway Hyperresponsiveness
The purpose of this study is to determine if Xolair can reduce the abnormal increase in limitation to airflow in patients with asthma in a relatively short time period. Another purpose is to determine if Xolair will decrease the amount of inflammation in the lungs of an asthmatic patient in the same time period.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- An Efficacy and Safety Study of Genolar® and Xolar® in the Persistent Atopic Bronchial Asthma#968799
- A Study of Efficacy of New Doses of Xolair to Protect From Allergen Challenge in Groups of Asthma Patients Defined by IgE Levels#1438924
- Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma#804141
- Study Using Xolair in Rush Multi Oral Immunotherapy in Multi Food Allergic Patients#906848
- ELLIPTA™ vs. MDI Inhaler Preference Study, in Adult Subjects With Asthma#1139050
Record · ID 1444850
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive